Metraipolis › archive › dc_6abdfe1fdf67

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity — Europe PMC PMID:42344364

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42344364
DOI
10.3389/fcvm.2026.1846253
License (as archived)
solo-consultazione
Archived
2026-10-31T16:02:45.371Z
SHA-256 of the archived text
0cdb7d0b307753f81def4e6eb88d52e644ab7ec59a65bc7a562a7528e10cb41c
Stable URL of this page
https://metraipolis.com/documento/dc_6abdfe1fdf67

How to cite

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity — Europe PMC PMID:42344364 — Europe PMC (en), https://europepmc.org/article/MED/42344364 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6abdfe1fdf67 (Metraipolis archive dc_6abdfe1fdf67, sha256 0cdb7d0b307753f81def4e6eb88d52e644ab7ec59a65bc7a562a7528e10cb41c)
BibTeX
@misc{dc6abdfe1fdf67,
  title = {SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity — Europe PMC PMID:42344364},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42344364},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6abdfe1fdf67; sha256 0cdb7d0b307753f81def4e6eb88d52e644ab7ec59a65bc7a562a7528e10cb41c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344364. Agents can read the archived copy with the MCP tool read_document.